Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Effects of a Perma-h Model Mobile-based Rehabilitation Support Program on Hope, Self-efficacy, Perceived Social Support and Rehabilitation Outcomes in Post- Tracheostomy Oral Cancer Patients
The Importance of Mucosal Screening in the Prevention of Oral Cancer.
Enhancing Oral Cancer Awareness
Collagen Matrix in Oral Cancer Surgery
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer
Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma